Building on our track record of delivering pioneering research we are working in collaboration with Cambridge University Hospitals NHS Trust, University of Cambridge and the Cancer Research UK (CRUK) Queen Mary University of London Cancer Prevention Trials Unit (CPTU) to deliver a clinical trial into the early detection of Oesophageal Cancer, the BEST4 Screening Study.  

This is an exciting project funded by CRUK and the National Institute for Health Research (NIHR). The trial aims to determine whether the Capsule Sponge test can be used to determine early diagnosis of cancer of the oesophagus and reduce the number of deaths due to oesophageal cancer.   

The BEST4 screening study will recruit 120,000 participants, of whom will be invited for a Capsule Sponge test on the BEST4 mobile units located in approximately 5 regions acros...